GMRE’s latest rating updates from top analysts.

Global Medical REIT Inc’s recent filing unveils that its CEO and President Decker Mark Okey Jr acquired Company’s shares for reported $0.67 million on Jun 24 ’25. In the deal valued at $6.52 per share,102,668 shares were bought. As a result of this transaction, Decker Mark Okey Jr now holds 102,668 shares worth roughly $0.73 million.

Then, Decker Mark Okey Jr bought 57,332 shares, generating $372,834 in total proceeds. Upon buying the shares at $6.50, the CEO and President now owns 160,000 shares.

A number of analysts have revised their coverage, including Berenberg’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Alliance Global Partners began covering GMRE with “Buy” recommendation on September 19, 2024. Robert W. Baird revised its rating on October 10, 2022. It rated GMRE as “a Neutral” which previously was an “an Outperform”.

Price Performance Review of GMRE

On Monday, Global Medical REIT Inc [NYSE:GMRE] saw its stock fall -2.06% to $7.12. Over the last five days, the stock has gained 5.79%. Global Medical REIT Inc shares have fallen nearly -20.47% since the year began. Nevertheless, the stocks have fallen -7.77% over the past one year. While a 52-week high of $10.35 was reached on 03/04/25, a 52-week low of $6.05 was recorded on 05/23/25.

Levels Of Support And Resistance For GMRE Stock

The 24-hour chart illustrates a support level at 7.04, which if violated will result in even more drops to 6.95. On the upside, there is a resistance level at 7.25. A further resistance level may holdings at 7.37.

How much short interest is there in Global Medical REIT Inc?

A steep rise in short interest was recorded in Global Medical REIT Inc stocks on 2025-06-13, growing by 0.22 million shares to a total of 2.0 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.78 million shares. There was a rise of 10.99%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.